Praesidia Biotherapeutics, Inc.
Biotechnology company · Arlington, Massachusetts, United States
Praesidia Biotherapeutics, Inc. is a biotechnology company headquartered in Arlington, Massachusetts, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $7.4 million sold in a notice filed in 2024.
Praesidia Biotherapeutics at a glance
What does Praesidia Biotherapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $7.4 million sold (2024).
Frequently asked questions about Praesidia Biotherapeutics
Where is Praesidia Biotherapeutics headquartered?
Praesidia Biotherapeutics, Inc. is headquartered in Arlington, Massachusetts, United States.
What does Praesidia Biotherapeutics do?
Praesidia Biotherapeutics, Inc. is a biotechnology company.
When was Praesidia Biotherapeutics founded?
The earliest incorporation on record for Praesidia Biotherapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- Eloxx Pharmaceuticals, Inc.Arlington, Massachusetts, United States
- Tetragenetics IncArlington, Massachusetts, United States
- Azyp, LLCArlington, Texas, United States
- Portal Biotechnologies, Inc.Arlington, Massachusetts, United States
- Haku Bio, Inc.Arlington, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences